More people are late on both their mortgage and student-loan payments — another bad sign for the economy
Student-loan delinquencies are rising sharply, as are delinquencies on mortgages backed by the Federal Housing Administration, according to a new report by the Federal Reserve Bank of New York.
'Stagflation is coming to the U.S.,' says this economist. Here's what it means for the dollar, bonds and stocks.
SoundHound earnings show a growing embrace of voice AI, and the stock is surging
'I'm tired of corporate America': My wife and I have $1.65 million. I'm 61. Can I retire already?
Trade Desk's stock may see its worst drop ever, and analysts wonder if Amazon is to blame
Shop Top Mortgage Rates
Your Path to Homeownership
A quicker path to financial freedom
Personalized rates in minutes
The New York Fed's data indicate that one-tenth of student-loan debt was reported as seriously delinquent in the second quarter of this year, meaning those borrowers were 90 days past due on payments.
The analysis also shows even though FHA mortgages — typically used by first-time and lower-income buyers — only make up about 12% of mortgage balances, the delinquency rate on those loans has been the steepest. Nearly 40% of borrowers with an FHA loan had missed a single payment — higher than the share of FHA borrowers who did so before the pandemic, in the first quarter of 2019, New York Fed researchers said.
Both the student-loan and FHA-delinquency trends come at a time when the U.S. economy is showing signs of weakness.
If younger people are 'drowning in debt' and the labor market starts to crack, 'this gets uglier fast,' Orphe Divounguy, an economist at Zillow Z, wrote on LinkedIn. July's jobs data, released last week, showed a marked slowdown in hiring.
As more young, aspiring homeowners see their credit scores drop from the impact of student-loan delinquencies, it will likely take time for them to bring their scores up to a level that would allow them to take on a mortgage, Divounguy told MarketWatch in an interview.
That could lead to lower demand for housing in the future and would be bad news for the industry, which last year saw home sales fall to the lowest level in about 30 years, according to the National Association of Realtors. Home sales have remained subdued for most of this year.
'The rise in defaults on student debt is especially concerning,' Jessica Lautz, deputy chief economist at NAR, told MarketWatch, 'as the share of first-time home buyers has already declined to record lows and the age of first-time home buyers has hit all-time highs.' The typical first-time buyer in the U.S. is now 38 years old, compared with age 35 the year before.
If we were to see the job market weaken further and layoffs increase, then we would 'need to worry about the U.S. economy,' Divounguy said. Should people who are already falling behind on their auto-loan, credit-card and student-loan payments end up losing their jobs, the economy would face a 'massive headwind' as consumer spending takes a hit, he added.
Related: Home prices hit an all-time high, but some regions are seeing price declines
Jake Krimmel, a senior economist at Realtor.com, said that he's more worried about the increase in delinquencies among homeowners who have an FHA-backed mortgage. While FHA loans make up a relatively small share of the market, they're over four times more likely than non-FHA loans to fall into delinquency, he told MarketWatch.
The rise in mortgage delinquencies may also be an early indicator of distress among American consumers. 'The real warning sign is that rising mortgage delinquencies may signal a softening labor market,' Krimmel said. 'This is especially true in certain regions and among lower-income households.'
Most of these FHA mortgages are concentrated in the South, where home prices are falling the fastest. Homeowners in that region are increasingly cutting prices to sell homes, per Realtor.com data. (Realtor.com is operated by News Corp subsidiary Move Inc.; MarketWatch publisher Dow Jones is also a subsidiary of News Corp.) The New York Fed's analysis found FHA delinquencies were relatively more elevated in Southern states and Puerto Rico.
'If price declines continue, some recent FHA borrowers may find themselves underwater, increasing the risk of distressed sales and putting further downward pressure on prices in those markets,' Krimmel said.
The share of homeowners who are underwater on their mortgages — meaning that they owe more on their mortgage balance than what their home would sell for in the current market — has been growing recently.
The percentage of mortgages that are underwater was highest in June in places where prices skyrocketed during the pandemic, such as Cape Coral, Fla., and Austin, Texas, according to data provided to MarketWatch by Intercontinental Exchange ICE.
Falling home prices could serve as a double whammy for these homeowners: Not only are they grappling with missed debt payments, but they could also potentially lose money on their home if they were forced to sell.
To be sure, it is 'too early to say this is happening at scale,' Krimmel noted, though it is a trend worth watching closely.
Below is a map of the top five markets where homeowners with a mortgage had the highest share of negative home equity, as of June 2025.
Trade Desk's stock tumbles after earnings. Are investors being too harsh?
'This scam stuff is going to get worse': A man approached me in my car — he had a crazy story
Why Fortinet's stock just saw one of its worst drops on record
'I feel shaken': A man offered to powerwash my patio for $50. He would not take no for an answer.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
Inspire Medical Systems, UFP Technologies, Globus Medical, Neogen, and Dentsply Sirona Shares Skyrocket, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower interest rates. Lower rates typically reduce borrowing costs for businesses and make stocks more attractive relative to bonds, contributing to widespread gains across sectors like healthcare. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Medical Devices & Supplies - Specialty company Inspire Medical Systems (NYSE:INSP) jumped 3%. Is now the time to buy Inspire Medical Systems? Access our full analysis report here, it's free. Drug Development Inputs & Services company UFP Technologies (NASDAQ:UFPT) jumped 3.5%. Is now the time to buy UFP Technologies? Access our full analysis report here, it's free. Medical Devices & Supplies - Specialty company Globus Medical (NYSE:GMED) jumped 3%. Is now the time to buy Globus Medical? Access our full analysis report here, it's free. Medical Devices & Supplies - Diversified company Neogen (NASDAQ:NEOG) jumped 3.4%. Is now the time to buy Neogen? Access our full analysis report here, it's free. Dental Equipment & Technology company Dentsply Sirona (NASDAQ:XRAY) jumped 3.1%. Is now the time to buy Dentsply Sirona? Access our full analysis report here, it's free. Zooming In On UFP Technologies (UFPT) UFP Technologies's shares are very volatile and have had 24 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 7 days ago when the stock gained 11.9% on the news that the company posted record second-quarter results and beat analyst profit expectations. The medical products company reported a 37.2% surge in sales to $151.2 million compared to the same period last year. Its adjusted earnings per share reached $2.50, which surpassed Wall Street's consensus estimate of $2.25. This strong performance was primarily driven by a 46% jump in its MedTech business, fueled by demand in areas like robotic-assisted surgery. However, the results included a 20% decline in its Advanced Components division, and the company noted increased labor costs pressured margins. UFP Technologies is down 10.2% since the beginning of the year, and at $221.03 per share, it is trading 38.3% below its 52-week high of $358.42 from September 2024. Investors who bought $1,000 worth of UFP Technologies's shares 5 years ago would now be looking at an investment worth $5,057. Unless you've been living under a rock, it should be obvious by now that generative AI is going to have a huge impact on how large corporations do business. While Nvidia and AMD are trading close to all-time highs, we prefer a lesser-known (but still profitable) semiconductor stock benefiting from the rise of AI. Click here to access our free report on our favorite semiconductor growth story.
Yahoo
22 minutes ago
- Yahoo
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed inflation rose by a modest 0.2% in July and 2.7% over the last year. This cooler-than-expected data prompted a significant market rally, with the S&P 500, Dow, and Nasdaq all climbing as investors grew more optimistic. The prevailing view is that easing inflation gives the central bank room to lower interest rates. Lower rates typically reduce borrowing costs for businesses and make stocks more attractive relative to bonds, contributing to widespread gains across sectors like healthcare. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Therapeutics company Moderna (NASDAQ:MRNA) jumped 3.1%. Is now the time to buy Moderna? Access our full analysis report here, it's free. Surgical Equipment & Consumables - Specialty company Teleflex (NYSE:TFX) jumped 4.1%. Is now the time to buy Teleflex? Access our full analysis report here, it's free. Dental Equipment & Technology company Envista (NYSE:NVST) jumped 3.1%. Is now the time to buy Envista? Access our full analysis report here, it's free. Medical Devices & Supplies - Specialty company Enovis (NYSE:ENOV) jumped 3.5%. Is now the time to buy Enovis? Access our full analysis report here, it's free. Health Insurance Providers company UnitedHealth (NYSE:UNH) jumped 3%. Is now the time to buy UnitedHealth? Access our full analysis report here, it's free. Zooming In On Teleflex (TFX) Teleflex's shares are not very volatile and have only had 5 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 6 months ago when the stock dropped 22.9% on the news that the company reported disappointing fourth-quarter results, with revenue missing expectations by a significant margin. On a constant currency basis, revenue increased 3.2%, but this still fell short of Wall Street's estimates. Weak demand in Interventional Urology wiped out gains in the Interventional and Surgical units. Looking ahead, the company's 2025 revenue guidance implies little to no growth, with management projecting revenue to be flat to slightly up. Overall, this was a weaker quarter, weighed down by sluggish growth, margin pressures, and a subdued outlook. Teleflex is down 32.8% since the beginning of the year, and at $120.33 per share, it is trading 51.3% below its 52-week high of $247.32 from September 2024. Investors who bought $1,000 worth of Teleflex's shares 5 years ago would now be looking at an investment worth $320.02. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
Yahoo
22 minutes ago
- Yahoo
Expedia Group Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Explore Expedia Group's Fair Values from the Community and select yours Expedia Group (NASDAQ:EXPE) Second Quarter 2025 Results Key Financial Results Revenue: US$3.79b (up 6.4% from 2Q 2024). Net income: US$330.0m (down 14% from 2Q 2024). Profit margin: 8.7% (down from 11% in 2Q 2024). The decrease in margin was driven by higher expenses. EPS: US$2.61 (down from US$2.93 in 2Q 2024). This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. All figures shown in the chart above are for the trailing 12 month (TTM) period Expedia Group Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 2.0%. Earnings per share (EPS) missed analyst estimates by 25%. Looking ahead, revenue is forecast to grow 6.0% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Hospitality industry in the US. Performance of the American Hospitality industry. The company's shares are up 4.1% from a week ago. Balance Sheet Analysis While earnings are important, another area to consider is the balance sheet. We have a graphic representation of Expedia Group's balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data